VOLITIONRX LTD — Director's Dealing 2021

Jul 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2021-07-14

Reporting Person: Colman Alan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-14	Stock Option (Right to Buy)	$4	D	10000	Disposed	2021-07-23	Common Stock (10000)	Direct
2021-07-14	Stock Option (Right to Buy)	$4	A	10000	Acquired	2025-07-23	Common Stock (10000)	Direct

Footnotes

F1: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on July 23, 2015, vested in full and were exercisable at 6 months from the date of grant, and as amended were exercisable for five years and six months from the date first exercisable. The "replacement" options are fully-vested and expire on July 23, 2025 (ten years from the date of grant).